SEC. 4554. IMPROVEMENTS <<NOTE: 42 USC 1395u note.>> IN ADMINISTRATION OF LABORATORY TESTS BENEFIT. (a) Selection of Regional Carriers.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary'') shall-- (A) divide the United States into no more than 5 regions, and (B) designate a single carrier for each such region, for the purpose of payment of claims under part B of title XVIII of the Social Security Act with respect to clinical diagnostic laboratory tests furnished on or after such date (not later than July 1, 1999) as the Secretary specifies. (2) Designation.--In designating such carriers, the Secretary shall consider, among other criteria-- (A) a carrier's timeliness, quality, and experience in claims processing, and [[Page 111 STAT. 461]] (B) a carrier's capacity to conduct electronic data interchange with laboratories and data matches with other carriers. (3) Single data resource.--The Secretary shall select one of the designated carriers to serve as a central statistical resource for all claims information relating to such clinical diagnostic laboratory tests handled by all the designated carriers under such part. (4) Allocation of claims.--The allocation of claims for clinical diagnostic laboratory tests to particular designated carriers shall be based on whether a carrier serves the geographic area where the laboratory specimen was collected or other method specified by the Secretary. (5) Secretarial exclusion.--Paragraph (1) shall not apply with respect to clinical diagnostic laboratory tests furnished by physician office laboratories if the Secretary determines that such offices would be unduly burdened by the application of billing responsibilities with respect to more than one carrier. (b) Adoption of National Policies for Clinical Laboratory Tests Benefit.-- (1) In general.--Not later than January 1, 1999, the Secretary shall first adopt, consistent with paragraph (2), national coverage and administrative policies for clinical diagnostic laboratory tests under part B of title XVIII of the Social Security Act, using a negotiated rulemaking process under subchapter III of chapter 5 of title 5, United States Code. (2) Considerations in design of national policies.--The policies under paragraph (1) shall be designed to promote program integrity and national uniformity and simplify administrative requirements with respect to clinical diagnostic laboratory tests payable under such part in connection with the following: (A) Beneficiary information required to be submitted with each claim or order for laboratory tests. (B) The medical conditions for which a laboratory test is reasonable and necessary (within the meaning of section 1862(a)(1)(A) of the Social Security Act). (C) The appropriate use of procedure codes in billing for a laboratory test, including the unbundling of laboratory services. (D) The medical documentation that is required by a medicare contractor at the time a claim is submitted for a laboratory test in accordance with section 1833(e) of the Social Security Act. (E) Recordkeeping requirements in addition to any information required to be submitted with a claim, including physicians' obligations regarding such requirements. (F) Procedures for filing claims and for providing remittances by electronic media. (G) Limitation on frequency of coverage for the same tests performed on the same individual. (3) Changes in laboratory policies pending adoption of national policy.--During the period that begins on the date of the enactment of this Act and ends on the date the Secretary first implements national policies pursuant to regulations promulgated under this subsection, a carrier under such [[Page 111 STAT. 462]] part may implement changes relating to requirements for the submission of a claim for clinical diagnostic laboratory tests. (4) Use of interim policies.--After the date the Secretary first implements such national policies, the Secretary shall permit any carrier to develop and implement interim policies of the type described in paragraph (1), in accordance with guidelines established by the Secretary, in cases in which a uniform national policy has not been established under this subsection and there is a demonstrated need for a policy to respond to aberrant utilization or provision of unnecessary tests. Except as the Secretary specifically permits, no policy shall be implemented under this paragraph for a period of longer than 2 years. (5) Interim national policies.--After the date the Secretary first designates regional carriers under subsection (a), the Secretary shall establish a process under which designated carriers can collectively develop and implement interim national policies of the type described in paragraph (1). No such policy shall be implemented under this paragraph for a period of longer than 2 years. (6) Biennial review process.--Not less often than once every 2 years, the Secretary shall solicit and review comments regarding changes in the national policies established under this subsection. As part of such biennial review process, the Secretary shall specifically review and consider whether to incorporate or supersede interim policies developed under paragraph (4) or (5). Based upon such review, the Secretary may provide for appropriate changes in the national policies previously adopted under this subsection. (7) Requirement and notice.--The Secretary shall ensure that any policies adopted under paragraph (3), (4), or (5) shall apply to all laboratory claims payable under part B of title XVIII of the Social Security Act, and shall provide for advance notice to interested parties and a 45-day period in which such parties may submit comments on the proposed change. (c) Inclusion of Laboratory Representative on Carrier Advisory Committees.--The Secretary shall direct that any advisory committee established by a carrier to advise such carrier with respect to coverage and administrative policies under part B of title XVIII of the Social Security Act shall include an individual to represent the independent clinical laboratories and such other laboratories as the Secretary deems appropriate. The Secretary shall consider recommendations from national and local organizations that represent independent clinical laboratories in such selection.
Sunday, December 9, 2018
1997 Balanced Budget Act, Section 4554: Uniform CMS Lab Claims Policies
https://www.gpo.gov/fdsys/pkg/PLAW-105publ33/html/PLAW-105publ33.htm
Labels:
4554,
bba,
negotiatedrulemaking
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.